CIIHF(CIIHF)
CIIHF
No analyst ratings available
No analyst price targets available for CIIHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $96.21B | $103.38B | $112.14B |
| Low | $92.06B | $94.60B | $107.31B |
| High | $108.98B | $130.47B | $127.02B |
| EBITDA Avg | $8.83B | $9.27B | $9.90B |
| Low | $8.45B | $8.86B | $9.44B |
| High | $10.02B | $10.55B | $11.30B |
| EBIT Avg | $6.87B | $7.42B | $8.10B |
| Low | $6.49B | $7.00B | $7.65B |
| High | $8.06B | $8.70B | $9.50B |
| Net Income Avg | $5.13B | $5.54B | $6.05B |
| Low | $4.84B | $5.23B | $5.71B |
| High | $6.02B | $6.49B | $7.09B |
| EPS Avg | $2.69 | $2.91 | $3.18 |
| Low | $2.54 | $2.75 | $3.00 |
| High | $3.16 | $3.41 | $3.73 |
| Analysts (Rev / EPS) | 8 / 1 | 11 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $20.19B | $21.00B | $22.42B | $23.35B | $23.35B | $24.29B |
| Low | $20.19B | $21.00B | $22.42B | $23.35B | $23.35B | $24.29B |
| High | $20.19B | $21.00B | $22.42B | $23.35B | $23.35B | $24.29B |
| EBITDA Avg | $2.38B | $2.42B | $2.47B | $2.52B | $2.49B | $2.54B |
| Low | $2.38B | $2.42B | $2.47B | $2.52B | $2.49B | $2.54B |
| High | $2.38B | $2.42B | $2.47B | $2.52B | $2.49B | $2.54B |
| EBIT Avg | $1.33B | $1.40B | $1.49B | $1.58B | $1.58B | $1.66B |
| Low | $1.33B | $1.40B | $1.49B | $1.58B | $1.58B | $1.66B |
| High | $1.33B | $1.40B | $1.49B | $1.58B | $1.58B | $1.66B |
| Net Income Avg | $995M | $1.05B | $1.11B | $1.18B | $1.18B | $1.24B |
| Low | $995M | $1.05B | $1.11B | $1.18B | $1.18B | $1.24B |
| High | $995M | $1.05B | $1.11B | $1.18B | $1.18B | $1.24B |
| EPS Avg | $0.53 | $0.55 | $0.59 | $0.62 | $0.62 | $0.66 |
| Low | $0.53 | $0.55 | $0.59 | $0.62 | $0.62 | $0.66 |
| High | $0.53 | $0.55 | $0.59 | $0.62 | $0.62 | $0.66 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |